{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:07:09Z","timestamp":1787828829729,"version":"build-2784847793"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1053\/j.semdp.2011.07.002","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T11:34:41Z","timestamp":1319715281000},"page":"283-297","source":"Crossref","is-referenced-by-count":17,"title":["Myelodysplastic\/myeloproliferative neoplasms"],"prefix":"10.1053","volume":"28","author":[{"given":"Elizabeth","family":"Hyjek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Vardiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2011.07.002_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/leu.2008.119","article-title":"The myelodysplastic\/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features","volume":"22","author":"Orazi","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib3","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"76","article-title":"Chronic myelomonocytic leukemia","author":"Orazi","year":"2008"},{"key":"10.1053\/j.semdp.2011.07.002_bib4","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"80","article-title":"Atypical chronic myeloid leukemia, BCR-ABL1 negative","author":"Vardiman","year":"2008"},{"key":"10.1053\/j.semdp.2011.07.002_bib5","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"82","article-title":"Juvenile myelomonocytic leukaemia","author":"Baumann","year":"2008"},{"key":"10.1053\/j.semdp.2011.07.002_bib6","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"85","article-title":"Myelodysplastic\/myeloproliferative neoplasm, unclassifiable","author":"Vardiman","year":"2008"},{"key":"10.1053\/j.semdp.2011.07.002_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1471-2407-8-299","article-title":"Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes","volume":"8","author":"Gelsi-Boyer","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1053\/j.semdp.2011.07.002_bib8","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/leu.2009.48","article-title":"RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutation at the C-terminal region might predict acute myeloid leukemia transformation","volume":"23","author":"Kuo","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib9","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3324\/haematol.2010.021808","article-title":"Transcription factor mutations in myelodysplastic\/myeloproliferative neoplasms","volume":"95","author":"Ernst","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.002_bib10","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2011.07.002_bib11","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3324\/haematol.2009.011205","article-title":"TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia","volume":"94","author":"Kosmider","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.002_bib12","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1182\/blood-2009-02-205690","article-title":"Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic\/myeloproliferative neoplasms","volume":"113","author":"Jankowska","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/leu.2009.59","article-title":"Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS\/MPN and AML","volume":"23","author":"Tefferi","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib14","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2009.27.1361","article-title":"Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS and RUNX1","volume":"28","author":"Kohlmann","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.002_bib15","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1182\/blood-2010-03-274704","article-title":"Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value","volume":"116","author":"Smith","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/leu.2011.10","article-title":"Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance","volume":"25","author":"Grossmann","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib17","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1158\/0008-5472.CAN-08-2754","article-title":"250 K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitution of c-Cbl, in myeloid malignancies","volume":"68","author":"Dunbar","year":"2008","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2011.07.002_bib18","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1182\/blood-2008-12-194548","article-title":"Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms","volume":"113","author":"Grand","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib19","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1200\/JCO.2009.23.7503","article-title":"Mutations of e3 ubiquitin ligase Cbl family members constitute a novel common pathogenic lesion in myeloid malignancies","volume":"27","author":"Makishima","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.002_bib20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"145","author":"Gelsi-Boyer","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.07.002_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.2010.08381.x","article-title":"ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia","volume":"151","author":"Gelsi-Boyer","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.07.002_bib22","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/leu.2011.58","article-title":"Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase of myeloproliferative neoplasms","volume":"25","author":"Abdel-Wahab","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2011.07.002_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2011.07.002_bib25","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/leu.2010.52","article-title":"Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS\/myeloproliferative neoplasms","volume":"24","author":"Kosmider","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2141.2010.08393.x","article-title":"Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukemia reveals a genetic profile distinct form chronic myelomonocytic leukemia","volume":"151","author":"Perez","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.07.002_bib27","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"49","article-title":"Chronic myelomonocytic leukaemia","author":"Vardiman","year":"2001"},{"key":"10.1053\/j.semdp.2011.07.002_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","article-title":"The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia","volume":"87","author":"Bennett","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.07.002_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0145-2126(97)00192-6","article-title":"Problems in the classification of CMML\u2014dysplastic versus proliferative type","volume":"10","author":"Germing","year":"1998","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.07.002_bib30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V99.3.840","article-title":"Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients","volume":"99","author":"Onida","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S0145-2126(00)00159-4","article-title":"Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia\u2014distinct subgroups or two stages of the same disease","volume":"25","author":"Voglov\u00e1","year":"2001","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.07.002_bib32","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/1042819042000207271","article-title":"Risk assessment in chronic myelomonocytic leukemia (CMML)","volume":"45","author":"Germing","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.07.002_bib33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/10428190701216386","article-title":"Prognostic factors and risk assessment in chronic myelomonocytic leukemia: Validation study of the M.D. Anderson Prognostic scoring system","volume":"48","author":"Beran","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.07.002_bib34","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3324\/haematol.11051","article-title":"Chronic myelomonocytic leukemia in the light of the WHO proposals","volume":"92","author":"Germing","year":"2007","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.002_bib35","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/leu.2008.162","article-title":"Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia","volume":"22","author":"Emanuel","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib36","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/1042819021000016186","article-title":"Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"43","author":"Saif","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.07.002_bib37","first-page":"171","article-title":"Chronic lymphocytic leukemia coexisting with chronic myelomonocytic leukemia","volume":"77","author":"Ferrara","year":"1992","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.002_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/10428199609054871","article-title":"Incidence and characteristics of lymphoid malignancies in untreated myelodysplastic syndromes","volume":"23","author":"Florensa","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.07.002_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/10428190009054897","article-title":"Occurrence of angioimmunoblastic T cell lymphoma in a patient with chronic myelomonocytic leukemia features","volume":"40","author":"Gaulier","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.07.002_bib40","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1080\/1042819031000110946","article-title":"Chronic myelomonocytic leukemia coexisting with B-cell chronic lymphocytic leukemia","volume":"44","author":"Robak","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.07.002_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3816\/CLK.2007.n.031","article-title":"Unmasking of chronic meylomonocytic leukemia after treatment of chronic lymphocytic leukemia with rituximab","volume":"6","author":"Bobek","year":"2007","journal-title":"Clinical Leuk"},{"key":"10.1053\/j.semdp.2011.07.002_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10428199309148501","article-title":"Chronic myelomonocytic leukaemia (CMML)\u2014a myelodysplastic or myeloproliferative syndrome?","volume":"9","author":"Michaux","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.07.002_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.V78.1.205.205","article-title":"Philadelphia-negative (Ph\u2212) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","volume":"78","author":"Martiat","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib44","first-page":"95","article-title":"Morphology and classification of the myelodysplastic syndromes and their pathologic variants","volume":"33","author":"Kouides","year":"1996","journal-title":"Semin Hematol"},{"key":"10.1053\/j.semdp.2011.07.002_bib45","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/modpathol.3800707","article-title":"Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology","volume":"19","author":"Orazi","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.07.002_bib46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2141.2008.07117.x","article-title":"Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia","volume":"141","author":"Ngo","year":"2008","journal-title":"B J Haematol"},{"key":"10.1053\/j.semdp.2011.07.002_bib47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0609.1992.tb01587.x","article-title":"Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients","volume":"48","author":"Maschek","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.semdp.2011.07.002_bib48","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/1097-0142(19920315)69:6<1457::AID-CNCR2820690625>3.0.CO;2-F","article-title":"Plasmacytoid monocytes proliferation associated with myeloproliferative disorders","volume":"69","author":"Baddoura","year":"1992","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2011.07.002_bib49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00000478-199101000-00011","article-title":"Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia","volume":"15","author":"Harris","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.07.002_bib50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00000478-200405000-00004","article-title":"Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders","volume":"28","author":"Vermi","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.07.002_bib51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1309\/HRJ1XKTD77J1UTFM","article-title":"Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis","volume":"124","author":"Xu","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.07.002_bib52","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3324\/haematol.11118","article-title":"A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes: expression of CD56 in CMML","volume":"92","author":"Lacronique-Gazaille","year":"2007","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.002_bib53","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.trsl.2008.03.001","article-title":"Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?","volume":"151","author":"Subir\u00e1","year":"2008","journal-title":"Transl Res"},{"key":"10.1053\/j.semdp.2011.07.002_bib54","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.2009.005801","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes","volume":"94","author":"Van de Loosdrecht","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.002_bib55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2010.030957","article-title":"Cytogenetic risk stratification in chronic myelomonocytic leukemia","volume":"96","author":"Such","year":"2011","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.002_bib56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2141.1999.01537.x","article-title":"Isolated isochromosome 17q: a distinct type of mixed myeloproliferative\/myelodysplastic syndrome with an aggressive clinical course","volume":"106","author":"McClure","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.07.002_bib57","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood.V76.6.1214.1214","article-title":"RAS mutations are rare events in Philadelphia chromosome-negative\/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia","volume":"76","author":"Hirsch-Ginsberg","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib58","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.leu.2401044","article-title":"Ras, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up","volume":"12","author":"Padua","year":"1998","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib59","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.leukres.2004.10.001","article-title":"Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"29","author":"Loh","year":"2005","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.07.002_bib60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/leu.2008.187","article-title":"High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia","volume":"23","author":"Tyner","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib61","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1158\/1078-0432.CCR-09-2112","article-title":"RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant","volume":"16","author":"Ricci","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2011.07.002_bib62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bcmd.2007.07.018","article-title":"Gatekeeper function of the RUNX1 transcription factor in acute leukemia","volume":"40","author":"Niebuhr","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.semdp.2011.07.002_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2011.07.002_bib64","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood.V96.9.3154","article-title":"Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis","volume":"96","author":"Imai","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib65","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydrozymethylcytosine in mammalian DNA by MLL patrner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"10.1053\/j.semdp.2011.07.002_bib66","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature09586","article-title":"Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2","volume":"468","author":"Ko","year":"2010","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2011.07.002_bib67","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/sj.leu.2403818","article-title":"Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?","volume":"19","author":"Vigui\u00e9","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jcp.20694","article-title":"The Cbl family proteins: ring leaders in regulation of cell signaling","volume":"209","author":"Swaminathan","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1053\/j.semdp.2011.07.002_bib69","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature08240","article-title":"Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms","volume":"460","author":"Sanada","year":"2009","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2011.07.002_bib70","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1074\/jbc.M109.065862","article-title":"ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1","volume":"285","author":"Lee","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semdp.2011.07.002_bib71","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1053\/j.semdp.2011.07.002_bib72","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2011.07.002_bib73","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2011.07.002_bib74","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2011.07.002_bib75","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations results in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2011.07.002_bib76","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2011.07.002_bib77","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib78","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jcp.2009.065904","article-title":"JAK2V617F activating mutation is associated with the myloproliferative type of chronic myelomonocytic leukaemia","volume":"62","author":"Pich","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.07.002_bib79","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G>T is rare in acute leukemia but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib80","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ncb814","article-title":"Nucleophosmin regulates the stability and transcriptional activity of p53","volume":"4","author":"Colombo","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1053\/j.semdp.2011.07.002_bib81","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature03915","article-title":"Role of nucleophosmin in embryonic development and tumorigenesis","volume":"437","author":"Grisendi","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2011.07.002_bib82","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2011.07.002_bib83","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2141.2006.06081.x","article-title":"C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders","volume":"133","author":"Caudill","year":"2006","journal-title":"B J Haematol"},{"key":"10.1053\/j.semdp.2011.07.002_bib84","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2008.17.9812","article-title":"Dysregulation of the C\/EBPalpha differentiation pathway in human cancer","volume":"27","author":"Koschmieder","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.002_bib85","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/1078-0432.CCR-04-1932","article-title":"Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia","volume":"11","author":"Shih","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2011.07.002_bib86","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.leu.2404770","article-title":"A tumor suppressor and oncogene: the WT1 story","volume":"21","author":"Yang","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000336","article-title":"The role of Wilms tumor gene (WT1) in normal and malignant haematopoiesis","volume":"9","author":"Ariyaratana","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"10.1053\/j.semdp.2011.07.002_bib88","first-page":"208","article-title":"P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?","volume":"8","author":"Melo","year":"1994","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.002_bib89","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.leukres.2006.12.025","article-title":"Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis","volume":"31","author":"Elliott","year":"2007","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.07.002_bib90","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1751-553X.2010.01246.x","article-title":"Recent advances in the diagnosis and classification of myeloid neoplasms\u2014comments on the 2008 WHO classification","volume":"32","author":"Yin","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"10.1053\/j.semdp.2011.07.002_bib91","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.leukres.2008.04.024","article-title":"Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm","volume":"32","author":"Fend","year":"2008","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.07.002_bib92","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3324\/haematol.2009.014001","article-title":"Molecular basis of myelodysplastic\/myeloproliferative neoplasms","volume":"94","author":"Reiter","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.002_bib93","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1365-2141.2008.07526.x","article-title":"Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category?","volume":"144","author":"Wardrop","year":"2009","journal-title":"Br J H\u00e6matol"},{"key":"10.1053\/j.semdp.2011.07.002_bib94","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.leukres.2010.02.033","article-title":"Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations","volume":"34","author":"Szpurka","year":"2010","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.07.002_bib95","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3324\/haematol.2009.013631","article-title":"Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis","volume":"95","author":"Flach","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.002_bib96","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2005-12-4769","article-title":"Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype","volume":"108","author":"Pellagatti","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.002_bib97","doi-asserted-by":"crossref","first-page":"e1970","DOI":"10.1371\/journal.pone.0001970","article-title":"The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts","volume":"3","author":"Boultwood","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1053\/j.semdp.2011.07.002_bib98","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2009-05-222331","article-title":"Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis","volume":"114","author":"Malcovati","year":"2009","journal-title":"Blood"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257011000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257011000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T15:46:18Z","timestamp":1593186378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257011000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0740257011000967"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2011.07.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}